Early Life Exposures And Development Of Non-communicable Diseases In Adolescence: The Drakenstein Child Health Study

Lead Research Organisation: Imperial College London
Department Name: National Heart and Lung Institute

Abstract

Non-communicable diseases are a major cause of ill health and premature death globally, with a particularly large burden in low- and middle-income countries. These include many common diseases, including respiratory disorders such as asthma and chronic obstructive pulmonary disease, heart disease, obesity, diabetes and mental illness. In low- and middle-income countries, these diseases occur at an earlier age and are more severe compared to high-income countries. Studies from high-income countries have shown that the roots of these diseases lie in childhood, and that their development through the life course tracks from early childhood into adolescence and adulthood. The burden and the type of exposures which adversely affect their development, such as pneumonia, tuberculosis, cigarette smoke, biomass exposure, allergens or intense level of stress, are very different in Africa compared to high-income countries. However, despite the high number of affected people and higher severity of non-communicable diseases, as well as many harmful environmental exposures, there are no data on early-life factors associated with their development in Africa.
Adolescence is an important period during which non-communicable diseases emerge and in which behaviours or exposures such as heightened risk-taking (for example smoking) and increased risk of infections (such as TB) may affect disease development. Importantly, adolescence is a period in which we may intervene to improve lifetime health. However, there are very limited studies on non-communicable diseases or early-life determinants in adolescents in low- and middle-income countries, especially in Africa. Identifying these is crucial to develop ways to prevent these diseases and reduce their burden.

Building on a unique South African birth cohort, the Drakenstein Child Health study, we wish to establish a resource for detailed study of non-communicable diseases in African adolescents and help researchers around the world to access many valuable datasets. To achieve this, in our study of 1000 mother-child pairs, we collected detailed measures of infectious diseases and non-infectious exposures through pregnancy and childhood, stored their biological samples, and completed repeated measurements of health from birth to age 8 years. We now propose to follow participants through the critical period of adolescence from 9 to 15 years of age, to measure heath status across broad domains (respiratory, heart disease, obesity, diabetes, mental health), and assess ongoing exposures. We will collect biological samples through this time, adding to the existing repository to enable many future studies to address mechanisms of how these diseases develop. We will consolidate and verify different data sets, so that they can be easily accessed and reused, thereby enhancing their global value. This will create a unique resource unparalleled anywhere in low- and middle-income countries, for study of non-communicable diseases.

We will bring together leading UK, South African and Australian experts, building African research capacity through collaborations and training. Our overall vision is to inform the development of intervention strategies to reduce the risk of non-communicable diseases and improve health during the key period of adolescence and into adulthood. This will be very important for the development of new strategies reduce disease burden, prevent ill health and premature death, an area of critical need.

Technical Summary

Non-communicable diseases (NCDs) are increasing globally, with a disproportionate burden in low- and middle-income countries (LMICs), where more than three quarters of global NCD deaths occur. Further, in LMICs, NCDs occur at an earlier age and with greater severity than in high-income countries. Adolescence is a key developmental period during which NCD phenotypes emerge, and specific behaviours or exposures may promote or prevent disease development. However, despite the high prevalence and severity of NCDs and many harmful environmental exposures, there are very limited data on NCD phenotypes or determinants in adolescents in LMICs.

This proposal builds on our work in the Drakenstein Child Health Study (DCHS), a birth cohort of 1000 exceptionally well phenotyped South African children who have been followed from antenatal period through age 8 years, including longitudinal assessment of symptoms, growth, adiposity, lung function, neurocognitive development and mental health measures, linked with a comprehensive collection of early life exposures, and very high retention (90%). We will extend the follow-up in DCHS through the critical period into adolescence (age 15years) with detailed phenotyping, measurements of relevant exposures and collection of biological material for research. We will apply FAIR (Findability, Accessibility, Interoperability, Reusability) guiding principles for data management and stewardship to enable efficient and error-free data analysis and increase reusability. Phenotypic data and linked samples in a biorepository will form an invaluable resource for research globally on adolescent NCDs (respiratory, cardio-vascular, mental health). FAIRified data assets will ensure wide global use and optimise potential impact. The overall vision is to identify modifiable risk factors and inform development of intervention strategies to reduce the risk of NCDs and prevent morbidity and premature death in African populations, an area of critical need.

Publications

10 25 50

publication icon
Custovic A (2023) Evolution of Lung Function within Individuals: Clinical Insights and Data-driven Methods. in American journal of respiratory and critical care medicine

publication icon
Custovic A (2023) Environmental influences on childhood asthma: Allergens. in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

publication icon
Custovic A (2022) Allergy Essentials

publication icon
Custovic D (2023) Understanding progression from pre-school wheezing to school-age asthma: Can modern data approaches help? in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

publication icon
Dramburg S (2023) EAACI Molecular Allergology User's Guide 2.0. in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

 
Description A concept for integrated care pathways for atopic dermatitis-A GA2 LEN ADCARE initiative
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a guidance/advisory committee
Impact The AD-ICPs outline the diagnostic procedures, possible co-morbidities, different available treatment options including differential approaches for the pediatric population, and the role of the pharmacists and other stakeholders, as well as remaining unmet needs in the management of AD.
 
Description EAACI Molecular Allergology User's Guide 2.0
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a guidance/advisory committee
Impact It is designed for both, clinicians and scientists, guiding health care professionals through the overwhelming list of different allergen molecules available for testing. Further, it provides diagnostic algorithms on the clinical relevance of allergenic molecules and gives an overview of their biology, the basic mechanisms of test formats, and the application of tests to measure allergen exposure.
 
Description International consensus statement on allergy and rhinology: Allergic rhinitis - 2023.
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a guidance/advisory committee
Impact ICAR-Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost.
 
Description Optimal Practices in Childhood Asthma Monitoring Among Multiple International Stakeholders
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a guidance/advisory committee
Impact Wider use of standardized instruments and the intensification of continuous between-visit monitoring, supported by electronic devices, is needed for further improvement of disease outcomes.
 
Description Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a guidance/advisory committee
Impact Modification of the previous WAO Grading system for SARs, which aligns with the newly-proposed Consortium for Food Allergy Research (CoFAR) Grading Scale for Systemic Allergic Reactions in Food Allergy (version 3.0).
 
Description GN3005 - Action Medical Research Research Training Fellowship Scheme
Amount £300,000 (GBP)
Funding ID GN3005 
Organisation Action Medical Research 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2023 
End 09/2026
 
Description Rosetrees 2023 Interdisciplinary Award
Amount £200,000 (GBP)
Organisation Rosetrees Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 09/2023 
End 09/2026
 
Title Multi-source data analytics to uncover asthma aetiology 
Description We extracted the reported symptoms, laboratory measures, omics data from MAAS, ALSPAC and U-BIOPRED, favouring the use of shared information across the studies. We cleaned the data to remove outliers and systematic errors that could affect the robustness of results. As results, three integrated datasets will be available. 
Type Of Material Improvements to research infrastructure 
Year Produced 2024 
Provided To Others? Yes  
Impact A series of ongoing analyses 
 
Title A meta-analysis of genome-wide association studies of childhood wheezing phenotypes 
Description We conducted a novel multivariate GWAS meta-analysis of wheezing phenotypes jointly derived using unbiased analysis of data collected from birth to 18 years in 9568 individuals from five UK birth cohorts. 
Type Of Material Data analysis technique 
Year Produced 2023 
Provided To Others? Yes  
Impact We identified a novel locus on chr9q21.13 (close to annexin 1 [ANXA1], p<6.7 × 10-9), associated exclusively with early-onset persistent wheeze. 
 
Title Evaluation of measurement errors in the Patient-Oriented Eczema Measure (POEM) outcome 
Description In the clinical trial data set, we developed novel ML methodology to find that patients tended to slightly underestimate their symptoms when reporting POEM, with significant variation in how well they were able to recall the frequency of their symptoms every time they reported POEM. 
Type Of Material Data analysis technique 
Year Produced 2024 
Provided To Others? Yes  
Impact A large recall noise should be taken into consideration when interpreting POEM scores. 
 
Title Identification of eczema clusters 
Description We derived six multidimensional variables of eczema spells from birth to 18 years of age (including duration, temporal sequencing and the extent of persistence/recurrence). We applied Partitioning Around Medoids clustering on these variables to derive clusters of the temporal patterns of eczema. 
Type Of Material Data analysis technique 
Year Produced 2023 
Provided To Others? Yes  
Impact Clustering of multidimensional variables identified stable clusters with different genetic architectures. Using multidimensional variables may capture eczema development and derive stable and internally homogeneous clusters. 
 
Title Obstructive and restrictive spirometry from school age to adulthood: 
Description We collated we and analysed pooled data from three UK population-based birth cohorts established between 1989 and 1995. 
Type Of Material Database/Collection of data 
Year Produced 2024 
Provided To Others? Yes  
Impact Foundation of further work with our European partners 
 
Description Interviews with parents of pre-school children with wheeze 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Patients, carers and/or patient groups
Results and Impact Recognising the importance of preschool wheeze, the European Respiratory Society set up the Task Force in 2022 led by the Co-I (SS). To establish priorities for parents and caregivers, we carried out interviews with parents of pre-school children with wheeze in the UK and the Netherlands (Prof H Pinnock). While parent/carers of children with preschool wheezing understood and appreciated the difficulty of making a precise diagnosis, current uncertainties surrounding the diagnosis and prognosis of preschool wheeze ("Is this asthma?", "Will my child go on to have asthma in later life?") left parents 'in limbo'. The key areas of unmet need where more information is needed from healthcare professionals were accurate diagnosis and long-term prognosis.
Year(s) Of Engagement Activity 2023
 
Description Parent's perception of respiratory syncytial virus and subsequent wheezing burden: A multi-country survey 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Patients, carers and/or patient groups
Results and Impact This cross-sectional online survey enrolled 1,200 parents with at least one child =6y living in the US, UK, Spain and Italy. We aimed to document the parents' perception of the link between RSV infection and subsequent wheezing, wheezing-related healthcare and family resources use, and its impact on the family daily life.
Year(s) Of Engagement Activity 2023